Pulmonary heart disease

Common Name(s)

Pulmonary heart disease

Pulmonary heart disease results from lung disorders that cause high blood pressure within the lungs. Normally blood flows from the heart, into the lungs, back to the heart, and then out to the rest of the body. Certain lung conditions can cause the blood pressure within the lungs to be abnormally high. This pressure causes the right side of the heart to work harder, which can injure and tire out the heart muscle. When the heart muscle tires out, this is called “heart failure”. Pulmonary heart disease is fairly rare and those who have it also have a lung disorder. Pulmonary heart disease can be diagnosed by a physician using imaging tests and various studies of heart function. Pulmonary heart disease is usually treated by addressing underlying causes. Certain medications and use of oxygen may also help to slow the progression of the disease.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Pulmonary heart disease" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Pulmonary heart disease" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Pulmonary heart disease" returned 282 free, full-text research articles on human participants. First 3 results:

Changes of heart rate variability predicting patients with acute exacerbation of chronic obstructive pulmonary disease requiring hospitalization after Emergency Department treatment.
 

Author(s): Chia-Ying Tseng, Julia Chia-Yu Chang, Yen-Chia Chen, Hsien-Hao Huang, Chien-Sheng Lin, Chorng-Kuang How, David Hung-Tsang Yen

Journal: J Chin Med Assoc. 2018 01;81(1):47-52.

 

Indexes of heart rate variability (HRV) appear to reflect severity and may have prognostic value in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). We hypothesized that AECOPD without adequate treatment response would demonstrate impaired cardiac ...

Last Updated: 31 Dec 1969

Go To URL
Semi-quantitative assessment of pulmonary arterial hypertension associated with congenital heart disease through myocardial perfusion imaging.
 

Author(s): Mei Liu, Chunxia Qin, Xiaotian Xia, Mengting Li, Yichun Wang, Lijun Wang, Xiaoke Shang, Xiaoli Lan

Journal: Hell J Nucl Med. ;20(3):204-210.

 

The study aimed to use myocardial perfusion imaging (MPI) as a semi-quantitative method to assess the clinical severity of pulmonary arterial hypertension (PAH) in patients with congenital heart disease (CHD).

Last Updated: 31 Dec 1969

Go To URL
Prognostic and diagnostic significance of copeptin in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 study.
 

Author(s): Jacob A Winther, Jon Brynildsen, Arne Didrik Høiseth, Heidi Strand, Ivar Følling, Geir Christensen, Ståle Nygård, Helge Røsjø, Torbjørn Omland

Journal:

 

Copeptin is a novel biomarker that predicts mortality in lower respiratory tract infections and heart failure (HF), but the diagnostic value of copeptin in acute dyspnea and the prognostic significance of copeptin in acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is not clear.

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Pulmonary heart disease" returned 59 free, full-text review articles on human participants. First 3 results:

Sleep-Disordered Breathing-a Real Therapeutic Target for Hypertension, Pulmonary Hypertension, Ischemic Heart Disease, and Chronic Heart Failure?
 

Author(s): Takaaki Nakamoto

Journal: J Nippon Med Sch. 2018 ;85(2):70-77.

 

Sleep-disordered breathing (SDB) is a risk factor for cardiovascular disease including acute coronary syndrome and acute myocardial infarction, and treating SDB prevents their development and recurrence and improves a patient's prognosis. Therefore, SDB is considered a therapeutic ...

Last Updated: 31 Dec 1969

Go To URL
Current Knowledge and Recent Advances of Right Ventricular Molecular Biology and Metabolism from Congenital Heart Disease to Chronic Pulmonary Hypertension.
 

Author(s): Samantha Guimaron, Julien Guihaire, Myriam Amsallem, François Haddad, Elie Fadel, Olaf Mercier

Journal:

 

Studies about pulmonary hypertension and congenital heart diseases have introduced the concept of right ventricular remodeling leading these pathologies to a similar outcome: right ventricular failure. However right ventricular remodeling is also a physiological process that enables ...

Last Updated: 31 Dec 1969

Go To URL
The efficiency of endothelin receptor antagonist bosentan for pulmonary arterial hypertension associated with congenital heart disease: A systematic review and meta-analysis.
 

Author(s): Hong-Yu Kuang, Yu-Hao Wu, Qi-Jian Yi, Jie Tian, Chun Wu, We Nian Shou, Tie-Wei Lu

Journal: Medicine (Baltimore). 2018 Mar;97(10):e0075.

 

Oral bosentan has been widely applied in pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD). A systemic review and meta-analysis was conducted for a therapeutic evaluation of oral bosentan in both adult and pediatric patients with PAH-CHD. The acute ...

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Effects of Secondhand Smoke on Flight Attendant Health
 

Status: Recruiting

Condition Summary: Cardiopulmonary Disease

 

Last Updated: 24 Oct 2017

Go to URL
IUGR, Respiratory Muscle Function, and Exercise Capacity in Childhood
 

Status: Recruiting

Condition Summary: Intrauterine Growth Restriction; Cardiopulmonary Disease

 

Last Updated: 30 Apr 2018

Go to URL
Evaluation of Cardiopulmonary Diseases by Ultrasound
 

Status: Recruiting

Condition Summary: Dyspnea; Acute Decompensated Heart Failure

 

Last Updated: 24 Jul 2018

Go to URL